Randal and Inger Kenworthy
Approach: Developing technology for earlier disease detection, better prognoses and enhanced treatment methods.
Strategic Area: disease detection
Approach: Developing a novel vaccine candidate against certain potential triggers of T1D, and an antibody to treat the disease (NASDAQ: PRVB)
Strategic Area: Immunotherapies
Approach: Uses industry-leading smart data capabilities to deliver best-in-class wind power solutions.
Strategic Area: Sustainable energy solutions
Approach: a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide
Strategic Area: Pharmaceuticals
Approach: A global leader in smart energy technologies
Strategic Area: Smart Energy, including solar.
More investments to come.